SNMMI and the Alzheimer's Association have developed draft appropriate use criteria for beta-amyloid imaging that are available for comment through Dec. 6. View and comment.
Published in Brief:
|Assistant General Counsel, Regulatory FDA||
|Assistant General Counsel||
|Regulatory Affairs Specialist||
|Sr. Principal OptoMechanical Engineer - 14000008M2||
|San Jose, CA|
|Senior Director Medical Affairs||